University of Arizona Researcher Rachna Shroff Dies

Dr. Rachna Shroff, a leader in clinical cancer research, has passed away at age 47.

Updated on Oct. 27, 2026 in Cancer

Bold flat-color editorial illustration of a geometric desert plant, evoking a sense of solemn reflection and quiet remembrance.
Dr. Rachna Shroff, a leading cancer researcher and associate director at the University of Arizona Cancer Center, has died at age 47. AI Illustration. Upload story photo >

Dr. Rachna Shroff, the associate director of clinical investigations at the University of Arizona Cancer Center, has died following a battle with an aggressive form of cancer. She was 47 years old.

Why it matters

Dr. Shroff was a pivotal figure in advancing cancer research and clinical investigation, leaving behind a significant legacy of advocacy and fundraising for scientific innovation.

Dr. Shroff raised over $1.3 million to endow a cancer research award during her career. Her clinical focus on gastrointestinal cancers was highlighted during her 2021 presentation at the Gastrointestinal Cancers Symposium.

The players

Rachna Shroff

She was the associate director of clinical investigations at the University of Arizona Cancer Center and a dedicated cancer researcher.

University of Arizona Cancer Center

This institution serves as a major hub for clinical investigations and cancer treatment research in Tucson.

The details

As the associate director of clinical investigations at the University of Arizona Cancer Center, Dr. Shroff dedicated her career to fighting the disease that ultimately claimed her life. She was well-known for her efforts to support the scientific community through an endowed research award she successfully funded.

Timeline

  1. Dr. Shroff spoke at the Gastrointestinal Cancers Symposium in 2021.

  2. A funeral for Dr. Rachna Shroff is scheduled for Friday, October 30, 2026.

Health Landscape

This loss marks a significant change in the leadership and ongoing research direction of the University of Arizona Cancer Center clinical investigation program. It highlights the immense impact individual clinical leaders have on the broader trajectory of cancer treatment research.

The passing of a key clinical investigator may shift the timelines or availability of certain oncology trials at the University of Arizona. Patients currently enrolled in studies under her direction should contact the center for updates on their specific care plans.

The takeaway

Dr. Shroffs commitment to funding research demonstrates the tangible impact that persistent advocacy can have on scientific advancement. Her legacy continues through the endowed award that will support future cancer investigators for years to come.

Further reading

Learn more about local efforts in the fight against the disease on our Tucson Cancer page.

Source note: This article includes information reported by Arizona Public Media.